| 2024年年报 | 2023年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 医药代理(元) | 130,698,609.23 | 134,021,866.34 |
| 医药制造(元) | 3,636,702,529.65 | 4,048,645,801.47 |
| 营业成本(元) | ||
| 医药代理(元) | 93,190,005.48 | 81,687,853.12 |
| 医药制造(元) | 1,499,612,164.46 | 1,481,877,500.76 |
| 毛利(元) | ||
| 医药代理(元) | 37,508,603.75 | 52,334,013.22 |
| 医药制造(元) | 2,137,090,365.19 | 2,566,768,300.71 |
| 毛利率(%) | ||
| 医药代理(%) | 28.70 | 39.05 |
| 医药制造(%) | 58.76 | 63.40 |
| 收入构成(%) | ||
| 医药代理(%) | 3.47 | 3.20 |
| 医药制造(%) | 96.53 | 96.80 |
| 毛利构成(%) | ||
| 医药代理(%) | 1.72 | 2.00 |
| 医药制造(%) | 98.28 | 98.00 |